Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 22, 1061-1066, October 1, 1962]
© 1962 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hampton, E. G.
Right arrow Articles by Eidinoff, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hampton, E. G.
Right arrow Articles by Eidinoff, M. L.

Transformation of Chick Embryo Cells in Culture by Rous Sarcoma Virus—Cytochemical Studies*

E. Gambetta Hampton and Maxwell L. Eidinoff

( Division of Biophysics, Sloan-Kettering Institute for Cancer Research, Sloan-Kettering Division of Cornell University Medical College, New York, New York)

Clusters of morphologically transformed cells (foci) resulting from infection of secondary cultures of chick embryo cells by Rous sarcoma virus (RSV) were compared with fibroblast-like cells outside the focal areas with the use of several cytochemical procedures. Transformed cells yielded greater precipitation of the dinitroformazan in a test involving the lactic acid dehydrogenase, NBT-reductase complex. Intracytoplasmic fluorescent material was observed in these cells following treatment with fluorescein-labeled anti-RSV serum. Differences were observed in the utilization of labeled precursors for nucleic acid synthesis following short exposures to uridine-H3 and thymidine-H3.

* Supported by grants from the National Institutes of Health (C-3811) and the U.S. Atomic Energy Commission (AT[30-1]-910).

Received 4/30/62.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1962 by the American Association for Cancer Research.